Answers are grounded in this paper and cite their sources.
Background: Healthcare is rapidly shifting toward disease prevention, driving a booming nutraceutical market that is redefining global wellness. At the forefront of this movement, ancient Ayurvedic traditions are merging with modern science, treating food as medicine to maintain bodily balance. While traditional herbal formulas have long struggled with low bioavailability and poor absorption, recent breakthroughs in drug delivery systems and computational biology are finally bridging that gap. This review explores how a decade of multidisciplinary research has successfully transformed traditional remedies into standardized, globally recognized therapeutics. Materials and methods: This study synthesises peer-reviewed literature from 2015 to 2026 across major databases to find out this changing landscape. Result: Bibliometric and thematic analyses reveal that current research evolves around four core pillars, such as phytochemical standardisation, advanced delivery systems, multi-target pharmacology and clinical validation. Despite this progress, the sector faces significant hurdles, including heavy metal contamination, microbial adulteration, inconsistent raw material quality, and fragmented global regulations across the FDA, EFSA, and FSSAI. Looking forward, the integration of Artificial Intelligence (AI) and machine learning offers a promising frontier for optimising polyherbal synergies and predicting drug-nutraceutical interactions. Conclusion: This review demonstrates that a decade of scientific studies has successfully transformed Ayurvedic nutraceuticals into a standardised, evidence-based opportunity for global integrative medicine.
No takes yet. Share an insight, caveat, or question.
S et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: